An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations
- 27 February 2023
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 117, 109934
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Genetic Engineering and Biotechnology
This publication has 128 references indexed in Scilit:
- Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathwaysNanomedicine: Nanotechnology, Biology and Medicine, 2014
- The history of Toll-like receptors — redefining innate immunityNature Reviews Immunology, 2013
- Developing mRNA-vaccine technologiesRNA Biology, 2012
- Viral Integration and Consequences on Host Gene Expression2012
- Widespread Horizontal Gene Transfer from Double-Stranded RNA Viruses to Eukaryotic Nuclear GenomesJournal of Virology, 2010
- Current prospects for mRNA gene deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cellsBlood, 2006
- Autism, inflammatory bowel disease, and MMR vaccineThe Lancet, 1998
- Autism, inflammatory bowel disease, and MMR vaccineThe Lancet, 1998
- Positively Charged Liposome Functions as an Efficient Immunoadjuvant in Inducing Immune Responses to Soluble ProteinsBiochemical and Biophysical Research Communications, 1997